Article
Drug monitoring and viral response to lopinavir/ritonavir or saquinavir/ritonavir containing regimens in individuals infected with the human immunodeficiency virus type 1.
International journal of immunopathology and pharmacology - 1 Jan 2000
Falkensammer B, Fasser W, Scherer K, Zemann A, Parson W, Ulmer H, Dierich M P, Stoiber H
Abstract excerpt
The aim of this study was to correlate results of therapeutic drug monitoring, genotypic resistance and viral response to lopinavir/ritonavir (LPV/r) or saquinavir/ritonavir (SQV/r) containing antiretroviral regimens. The retrospective short-term study included 20 patients with LPV/r and 20 patients with SQV/r containing highly active antiretroviral therapy (HAART). At baseline 7 LPV/r patients and 10 SQV/r...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.